<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Temporomandibular disorders in adults</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Temporomandibular disorders in adults</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Temporomandibular disorders in adults</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Noshir R Mehta, DMD, MS</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Keith, BDS, FDSRCS, DMD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark D Aronson, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Daniel G Deschler, MD, FACS</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Jane Givens, MD, MSCE</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 31, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H26338276"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Temporomandibular disorders (TMD) are commonly encountered by primary care providers. Although they have been classified in a number of different ways [<a href="#rid1">1</a>], they are most reasonably classified as a subtype of secondary headache disorder [<a href="#rid2">2</a>]. In 2020, a collaborative group (including the American Academy of Orofacial Pain [AAOP], the International Headache Society [IHS], the Orofacial and Head Pain Special Interest Group [OFHP SIG] of the International Association for the Study of Pain [IASP], and the International Network for Orofacial Pain and Related Disorders Methodology [INFORM]) produced the first International Classification of Orofacial Pain [<a href="#rid3">3</a>], the first comprehensive classification system dealing exclusively with orofacial pain conditions, which is modelled on the International Classification of Headache Disorders.</p><p>The goals of TMD management are to alleviate pain and to improve jaw function and quality of life.</p><p>This topic will review the epidemiology, pathogenesis, clinical manifestations, diagnosis, and treatment of TMD. The evaluation and management of temporomandibular joint (TMJ) dislocation is reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/6333.html" rel="external">"Temporomandibular joint (TMJ) dislocation"</a>.)</p><p class="headingAnchor" id="H1713551742"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>Temporomandibular disorders (TMD) are common, with a systematic review suggesting a prevalence as high as 31 percent in adults and 11 percent in children [<a href="#rid4">4</a>]. TMD is associated with substantial morbidity, affecting quality of life and work productivity. As an example, it is estimated that for every 100 million working adults in the United States, TMD contributes to 17.8 million lost workdays annually [<a href="#rid5">5</a>]. TMD patients have also been shown to use health care services at a higher rate, with a mean health care expenditure that is 1.6 times higher when compared with non-TMD individuals [<a href="#rid6">6</a>].</p><p>In observational studies:</p><p class="bulletIndent1"><span class="glyph">●</span>The prevalence of TMD is about 1.5 times higher in females than males [<a href="#rid7">7,8</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The greatest risk of onset of TMD is between the ages of 18 and 44 [<a href="#rid7">7</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Non-Hispanic White persons have a higher risk for TMD [<a href="#rid9">9</a>]. There does not seem to be an association with socioeconomic status.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is an association between chronic TMD and mood disorders as well as other psychiatric comorbidities [<a href="#rid10">10-17</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is an increased prevalence of TMD among patients with rheumatoid arthritis, ranging from 50 to 94 percent [<a href="#rid18">18-20</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>TMD may be associated with teeth grinding (bruxism) [<a href="#rid21">21</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>TMD is more common among people with medical comorbidities, other pain conditions, poor sleep quality, and cigarette smoking [<a href="#rid22">22</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Although there is a lack of high-quality evidence, repetitive jaw motions (eg, clenching, grinding, or gritting of teeth; gum chewing and pencil biting) and jaw positions (eg, scuba divers, violinists/violists, singers, woodwind players) are believed to be associated with TMD pain [<a href="#rid23">23</a>].</p><p></p><p class="headingAnchor" id="H548815367"><span class="h1">ANATOMY OF THE TMJ AND RELATED STRUCTURES</span><span class="headingEndMark"> — </span>The temporomandibular joint (TMJ), a hinged joint, is the articulation between the mandibular condyle and the glenoid fossa of the temporal bone  (<a class="graphic graphic_figure graphicRef64227" href="/z/d/graphic/64227.html" rel="external">figure 1</a>). The TMJ is a fibrocartilaginous joint, with a capsule, an articular disc, and synovial membranes.</p><p>The muscles of mastication which primarily affect TMJ function include the masseter, temporalis, and medial and lateral pterygoid muscles  (<a class="graphic graphic_figure graphicRef57658" href="/z/d/graphic/57658.html" rel="external">figure 2</a>). Innervation of these muscles is provided by branches of the motor division (V3) of the trigeminal nerve, which also innervate the muscles of the middle ear. In addition, the tensor tympani (the muscle within the ear responsible for dampening loud sounds) and the tensor palati (the muscle involved in soft palate elevation and eustachian tube function) wrap around the hamular notch of the posterior maxilla.</p><p class="headingAnchor" id="H1713551750"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>Temporomandibular disorders (TMD) were previously attributed solely to alterations in dental occlusion (the alignment of the upper and lower teeth) that affected maxillomandibular position and function. However, although there is a structural component to TMD, there are also multiple contributing and comorbid factors, including biological, behavioral, environmental, and cognitive, which can all contribute to the development of symptoms [<a href="#rid22">22,24-27</a>]. Decades of research have determined that TMD is not simply a manifestation of biomechanical issues but rather a complex disease involving an interplay of multiple genetic, psychological, and environmental domains [<a href="#rid22">22</a>]. Most experts consider chronic TMD a biopsychosocial pain condition with many features similar to other chronic pain disorders [<a href="#rid28">28,29</a>]. (See  <a class="medical medical_review" href="/z/d/html/116196.html" rel="external">"Evaluation of chronic non-cancer pain in adults", section on 'Chronic pain in context'</a>.)</p><p>Several factors can contribute to the development of TMD symptoms including:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Joint trauma </strong>– Trauma to the temporomandibular joint (TMJ) can result from cervical sprain injuries [<a href="#rid30">30</a>], bruxism, or injuries to the jaw [<a href="#rid31">31</a>]. Damage to the affected TMJ ligaments, articular cartilage, disc, and bone results in oxidative stress and generates free radicals within the intraarticular space. Subsequent synovial fluid inflammation produces cytokines that causes degenerative TMJ disease [<a href="#rid32">32-36</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Cervicogenic etiology </strong>– Poor head and cervical posture may contribute to TMD and pain because of the muscular attachments connecting the mandible, head, and neck [<a href="#rid37">37</a>]. Although in one systematic review, the poor methodology of included studies limited the ability to determine an association [<a href="#rid38">38</a>], in a subsequent small series, deep cervical plexus blocks were beneficial in relieving pain in some patients with orofacial and TMD pain [<a href="#rid39">39</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pain threshold and processing </strong>– There is a subjective component to the perception of pain in TMD; differences in pain modulation have been reported in individuals with TMD compared with healthy controls. As an example, in a small case-control study, females with TMD demonstrated lower pain tolerance than control subjects [<a href="#rid40">40</a>].</p><p></p><p class="bulletIndent1">Central pain processing may have a role in pain perception in patients with TMD. Among people with TMD, functional brain imaging studies demonstrated increased activation in cortical regions (eg, somatosensory, anterior cingulate, and prefrontal) and decreased thalamic activation [<a href="#rid41">41</a>]. This pattern of neural activation is similar to that seen in patients with other chronic pain disorders and may be related to abnormal pain processing in the trigeminal system. Myofascial pain disorders, in particular, may reflect a central sensitization or pain producing process [<a href="#rid42">42</a>]. (See  <a class="medical medical_review" href="/z/d/html/116196.html" rel="external">"Evaluation of chronic non-cancer pain in adults", section on 'Chronic pain in context'</a> and  <a class="medical medical_review" href="/z/d/html/116196.html" rel="external">"Evaluation of chronic non-cancer pain in adults", section on 'Definition of pain'</a>.)</p><p></p><p class="bulletIndent1">Furthermore, genetic studies suggest that in TMD patients, certain gene polymorphisms (eg, the catechol-O-methyl transferase [<em>COMT</em>] gene) might be associated with differences in pain response and processing [<a href="#rid43">43-45</a>].</p><p></p><p class="bulletIndent1">Among patients with TMD, there may be an association between increased sympathetic tone and the chronicity of symptoms [<a href="#rid46">46,47</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Psychological factors</strong> – Some studies support an association between chronic TMD and psychological conditions, including anxiety, depression, posttraumatic stress disorder, or a history of abuse [<a href="#rid10">10-15</a>]. In a small observational study, depression, compared with euthymia, was associated with an increased risk of TMJ pain  (<a class="graphic graphic_table graphicRef126435" href="/z/d/graphic/126435.html" rel="external">table 1</a>) [<a href="#rid48">48</a>].</p><p></p><p class="headingAnchor" id="H242703351"><span class="h1">CLINICAL MANIFESTATIONS</span><span class="headingEndMark"> — </span>Symptoms of temporomandibular disorder (TMD) are characterized by acute or chronic pain and may include pain and dysfunction of the temporomandibular joint (TMJ), headache, and earache. The anatomic source of pain can originate from the joint itself or from the muscles of mastication  (<a class="graphic graphic_figure graphicRef57658" href="/z/d/graphic/57658.html" rel="external">figure 2</a>).</p><p>In a retrospective study including over 4500 patients with TMD, the most common presenting signs and symptoms were [<a href="#rid49">49</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Pain (96 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Ear discomfort or dysfunction (82 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>Headache (80 percent)</p><p class="bulletIndent1"><span class="glyph">●</span>TMJ discomfort or dysfunction (75 percent)</p><p></p><p class="headingAnchor" id="H104372631"><span class="h2">Facial pain</span><span class="headingEndMark"> — </span>The pain of TMD is classically described as a dull, unilateral facial ache that is constant but waxes and wanes in intensity. The pain may radiate to the ear, temporal and periorbital regions, the angle of the mandible, and frequently to the posterior neck. It may be present intermittently, with many patients having pain-free periods, alternating with episodes of sharper, more intense pain. When present, it is aggravated by jaw motion. Patients may describe a "sinus" pain in the zygomatic or orbital area [<a href="#rid50">50</a>].</p><p>Nocturnal or daytime jaw clenching, tooth grinding, or other jaw habits may cause muscle discomfort or fatigue. Patients may notice this after meals and report a "heavy" and "tired" feeling in the jaw muscles chewing.</p><p class="headingAnchor" id="H1165514831"><span class="h2">Ear pain, fullness, and tinnitus</span><span class="headingEndMark"> — </span>TMD may also present with otologic symptoms, including otalgia, aural fullness, and tinnitus due to the close anatomic relationship with nerves that innervate the muscles of the ear [<a href="#rid51">51-54</a>]. (See <a class="local">'Anatomy of the TMJ and related structures'</a> above.)</p><p>Patients with internal derangement of the TMJ frequently report unilateral sharp, jabbing ear pain with jaw movement. Otalgia and other ear symptoms in the presence of a normal otologic examination are among the most common reasons to evaluate for TMD as the etiology of these symptoms.</p><p>Tinnitus can also have a peripheral musculoskeletal etiology (ie, somatic tinnitus) [<a href="#rid54">54</a>]. Specifically, cervical and mandibular postural factors (eg, repetitive movements and postures) that may affect musculoskeletal mechanics have been noted in some individuals with tinnitus. In some patients, tinnitus may be improved by altering maxillomandibular relationships and through manual physical therapy treatment focusing on the cervical paraspinal musculature. (See  <a class="medical medical_review" href="/z/d/html/6855.html" rel="external">"Etiology and diagnosis of tinnitus"</a>.)</p><p class="headingAnchor" id="H1165514956"><span class="h2">Headache</span><span class="headingEndMark"> — </span>The typical headache associated with TMD is described as pain that radiates to the jaw, temple, or forehead. It can be unilateral or bilateral and is typically dull, aching, continuous, moderate in intensity, and worse in the morning [<a href="#rid55">55-57</a>]. Morning TMD headaches may be related to nocturnal bruxism or sleep disorders [<a href="#rid58">58</a>], while discomfort that increases over the day may be due to masticatory muscle over-use or head and neck posture [<a href="#rid59">59</a>].</p><p>Some individuals present with headache without being aware of a TMD problem [<a href="#rid60">60-62</a>]. In addition to the typical headache, other types of TMD-related headache include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Frontal headache</strong> – Patients may complain of a "sinus headache" with accompanying pressure along the upper front teeth, bridge of the nose, and behind the eyes. Contractions or tension of the posterior neck muscles or frontalis muscle may also cause band-like pains in the front of the head.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Temporal headache</strong> – Temporal headaches related to TMD are primarily caused by muscle contraction and spasm of the temporalis muscles  (<a class="graphic graphic_figure graphicRef57658" href="/z/d/graphic/57658.html" rel="external">figure 2</a>). The anterior temporalis muscle fibers bring the lower jaw up and forward; the middle and posterior temporalis fibers swing the jaw closed and retract the mandible.</p><p></p><p class="bulletIndent1">Generally, the temporalis muscle is affected by any dysfunction of the lower jaw [<a href="#rid63">63</a>]. Headaches in the temporal area may be induced by recurrent pencil or pen biting or gum chewing. Teeth clenching, grinding, or biting on objects while the jaw is in an anteriorly displaced position causes pain in the anterior temporalis group  (<a class="graphic graphic_figure graphicRef57658" href="/z/d/graphic/57658.html" rel="external">figure 2</a>). In particular, individuals who work at computers where the head is kept forward and down may develop postural problems that can affect the TMJ and muscles of mastication.</p><p></p><p class="bulletIndent1">Bruxism during sleep fatigues the middle and posterior group of temporalis fibers, causing pain in a more posterior temporal location. Among patients with TMD and bruxism, the temporalis tendon attachment to the coronoid process of the mandible is frequently tender to palpation  (<a class="graphic graphic_figure graphicRef64227" href="/z/d/graphic/64227.html" rel="external">figure 1</a>); this is often overlooked during the evaluation of facial pain.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Occipital headache</strong> – Deep, dull, constant pain in the back of the head is usually caused by spasms of the trapezius and sternocleidomastoid muscles. When tensed or strained, these muscles pull on their bony attachments to the skull in the occiput and mastoid areas, leading to soreness in the bone and pain radiating to the back of the head and neck.</p><p></p><p class="headingAnchor" id="H1144190418"><span class="h2">Jaw and TMJ dysfunction</span><span class="headingEndMark"> — </span>Jaw and TMJ dysfunction manifest as decreased mandibular range of motion, clicking or popping noises with jaw movement, or jaw deviation to the affected side. Intermittent jaw locking may be present and is experienced as the temporary inability to open the mouth. Symptoms are usually worse in the morning with improvement and resolution over the day. The symptoms can, however, progress to permanent jaw locking in the closed position.</p><p class="headingAnchor" id="H1165515139"><span class="h2">Other symptoms</span><span class="headingEndMark"> — </span>Other symptoms which also may be associated with TMD include:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Neck pain</strong> – Cervical pain and stiffness are commonly associated with TMD symptoms [<a href="#rid64">64-67</a>]. Trauma, poor posture, and musculoskeletal tension in the cervical area may contribute to pain, stiffness, and trigger points in the muscles of the head and neck.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Orbital pain</strong> – Orbital and periorbital pain symptoms may be seen in patients with TMD and are typically unilateral and described as "boring" and constant [<a href="#rid50">50,68-70</a>]. (See <a class="local">'Headache'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Dizziness</strong> – Individuals with TMD may experience dizziness or vertigo that is associated with aural fullness or otalgia. In such cases, other causes of dizziness should be considered. (See  <a class="medical medical_review" href="/z/d/html/5099.html" rel="external">"Approach to the patient with dizziness"</a>.)</p><p></p><p class="headingAnchor" id="H26338311"><span class="h1">EVALUATION</span></p><p class="headingAnchor" id="H2329555876"><span class="h2">Diagnosis typically established by history and physical examination</span><span class="headingEndMark"> — </span>The diagnosis of temporomandibular disorders (TMD) is based primarily upon the history, including the patient's constellation of symptoms, and compatible physical examination findings.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>History</strong> – For all patients with suspected TMD, we perform a focused history with specific attention to [<a href="#rid71">71</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Facial pain, including the nature and location of the discomfort, and any aggravating and relieving factors.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Jaw symptoms, including pain with jaw function, limitation of jaw movement, cracking or popping noise with jaw function, and jaw muscle fatigue after eating.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Ear symptoms, including pain, aural fullness, tinnitus, vertigo, hearing loss.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Pain in the head, neck, shoulder, and upper back [<a href="#rid72">72</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Headaches, including "sinus headache" and temporal or occipital pain.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A history of previous TMJ surgery or trauma.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>A history of arthritis (including osteoarthritis or inflammatory arthritis).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>"Habits" such as pencil biting, gum chewing, or clenching, gritting or grinding of teeth.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hobbies or occupational factors (eg, scuba diving, violin or woodwind instrument playing, singing).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Bruxism, either night (sleep-related) or daytime (awake).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Evaluation for depression and anxiety as well as the presence of other chronic pain symptoms [<a href="#rid73">73</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Sleep quality [<a href="#rid27">27</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Physical examination-</strong> We perform a focused physical examination with attention to the TMJ as well as the surrounding structures of the head and neck:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Abnormal mandibular movements</strong> – We ask the patient to open and close their mouth, observing for any jaw deviation or protrusion with these movements [<a href="#rid74">74</a>]. We check for normal alignment of upper teeth and lower teeth  (<a class="graphic graphic_picture graphicRef129212" href="/z/d/graphic/129212.html" rel="external">picture 1</a>).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Decreased TMJ range of motion</strong> – We evaluate the range of motion of the TMJ by measuring the distance between the incisal edges of the upper and lower teeth when asking the patient to open their mouth as wide as possible. The normal functional opening is 35 to 55 mm [<a href="#rid23">23,74</a>]; in patients with TMD, it is typically less than 25 mm and is often associated with pain.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Palpation for tenderness and crepitus</strong> – We palpate the muscles of mastication (including the masseter, temporalis, and medial and lateral pterygoids), assessing for muscle tenderness [<a href="#rid75">75</a>]. We also palpate the lateral pole of the mandibular condyle  (<a class="graphic graphic_figure graphicRef64227" href="/z/d/graphic/64227.html" rel="external">figure 1</a>) for tenderness and feel for joint crepitus (clicking or crunching during opening and closing movements).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Pain with dynamic loading</strong> – We have the patient bite down with a cotton roll or tongue blade between the upper and lower canine teeth on each side; this compresses the contralateral TMJ and will cause pain if inflammation is present in the joint Alternatively, this can be evaluated by grasping the mandible on both sides, pressing down and back, compressing the TMJ bilaterally [<a href="#rid74">74</a>].</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Evaluate for bruxism</strong> – We examine the dentition, looking for signs of tooth wear (teeth that are fractured, chipped, or with areas of worn enamel on the chewing surfaces). The patient can also be referred to a dental professional for evaluation of bruxism.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Postural asymmetry</strong> – We assess upper body and neck posture, inspecting for slouching or a preference to lean to one side.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Neuromuscular examination of the head, neck, and face</strong> – We inspect and palpate the muscles of the neck (anterior and posterior) and shoulders, assessing for muscle tension, generalized tenderness, or focal trigger points. In addition, we perform a general cranial nerve examination with a focused examination specifically checking for decreased sensation in the trigeminal nerve (CN V) distribution and facial nerve (CN VII) function.</p><p></p><p class="headingAnchor" id="H3691165"><span class="h2">Imaging for patients with severe or persistent symptoms</span><span class="headingEndMark"> — </span>For the majority of patients in whom TMD is suspected, the diagnosis can be made based upon the history and physical examination alone. However, for patients with more severe symptoms and those with persistent symptoms that fail to respond to education and self-care, we obtain imaging to rule out local pathology in the teeth and jaw bones; a screening panoramic radiograph or cone beam computed tomography (CBCT) are both reasonable choices. We advise against the routine use of a standard radiograph of the TMJ, as this study does not provide valuable information regarding dentition and mandibular alignment and symmetry.</p><p>In addition, for those patients in whom the diagnosis remains uncertain (eg, for those without typical historical features or findings on physical examination), or for those in whom another diagnosis is suspected (eg, a mandibular or soft tissue tumor, sinus infection), further imaging may be necessary:</p><p class="bulletIndent1"><span class="glyph">●</span>If sinusitis is a concern, CT of the sinuses without contrast can be done; if CT scan is not available, sinus radiographs can be obtained.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The mandible and surrounding soft tissues, including the neck, parotid glands, and the muscles of mastication, can be evaluated with CT. In addition, the structure of the TMJ can be imaged in greater detail with magnetic resonance imaging (MRI).</p><p></p><p class="headingAnchor" id="H1372548275"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Although a careful history and physical examination will typically distinguish between the numerous causes of orofacial pain, some potentially serious disorders may present with similar symptoms [<a href="#rid76">76</a>]. (See  <a class="medical medical_review" href="/z/d/html/3355.html" rel="external">"Overview of craniofacial pain"</a>.)</p><p>Such disorders include:</p><p class="bulletIndent1"><span class="glyph">●</span>Dental disorders, including malocclusion, dental abscess, caries, and periodontal disease. (See  <a class="medical medical_review" href="/z/d/html/3417.html" rel="external">"Epidemiology, pathogenesis, and clinical manifestations of odontogenic infections"</a> and  <a class="medical medical_review" href="/z/d/html/6858.html" rel="external">"Overview of gingivitis and periodontitis in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Benign disorders of the parotid glands. (See  <a class="medical medical_review" href="/z/d/html/13962.html" rel="external">"Suppurative parotitis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/117718.html" rel="external">"Salivary gland swelling: Evaluation and diagnostic approach"</a> and  <a class="medical medical_review" href="/z/d/html/6854.html" rel="external">"Salivary gland stones", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Acute and chronic rhinosinusitis. (See  <a class="medical medical_review" href="/z/d/html/6871.html" rel="external">"Acute sinusitis and rhinosinusitis in adults: Clinical manifestations and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/7528.html" rel="external">"Chronic rhinosinusitis: Clinical manifestations, pathophysiology, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Otologic disorders, including acute otitis media, otitis media with effusion, Eustachian tube dysfunction, middle ear trauma, barotrauma, and causes of tinnitus. (See <a class="local">'Ear pain, fullness, and tinnitus'</a> above and  <a class="medical medical_review" href="/z/d/html/6872.html" rel="external">"Acute otitis media in adults", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/6872.html" rel="external">"Acute otitis media in adults", section on 'Otitis media with effusion'</a> and  <a class="medical medical_review" href="/z/d/html/6544.html" rel="external">"Evaluation and management of middle ear trauma", section on 'Evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/6845.html" rel="external">"Ear barotrauma"</a> and  <a class="medical medical_review" href="/z/d/html/6855.html" rel="external">"Etiology and diagnosis of tinnitus", section on 'Introduction'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Head and neck cancer, including tumors of the oropharynx, mandible, muscles, and salivary glands. (See  <a class="medical medical_review" href="/z/d/html/3393.html" rel="external">"Overview of the diagnosis and staging of head and neck cancer"</a> and  <a class="medical medical_review" href="/z/d/html/3400.html" rel="external">"Salivary gland tumors: Epidemiology, diagnosis, evaluation, and staging"</a> and  <a class="medical medical_review" href="/z/d/html/7722.html" rel="external">"Osteosarcoma: Epidemiology, pathology, clinical presentation, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Trigeminal neuralgia, which is classically described as recurrent brief episodes of sharp, superficial, lancinating pain in the distribution of one or more branches of the fifth cranial (trigeminal) nerve  (<a class="graphic graphic_figure graphicRef70877" href="/z/d/graphic/70877.html" rel="external">figure 3</a>). (See  <a class="medical medical_review" href="/z/d/html/5283.html" rel="external">"Trigeminal neuralgia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Glossopharyngeal neuralgia, which is less common than trigeminal neuralgia and is characterized by brief, paroxysmal episodes of severe, stabbing pain involving the ear, tonsillar fossa, base of the tongue, or under the angle of the jaw.</p><p></p><p class="bulletIndent1">If these symptoms occur, evaluation by an otorhinolaryngologist is mandatory as symptoms can be caused by a nasopharyngeal tumor or other malignancy of the upper aerodigestive tract. (See  <a class="medical medical_review" href="/z/d/html/3355.html" rel="external">"Overview of craniofacial pain", section on 'Glossopharyngeal neuralgia'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Postherpetic neuralgia, which is typically described as a burning discomfort, with many patients experiencing areas of anesthesia accompanied by thermal, tactile, pinprick, and vibratory deficits within the affected dermatomes. A history of skin rash is consistent with the diagnosis. (See  <a class="medical medical_review" href="/z/d/html/5289.html" rel="external">"Postherpetic neuralgia"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Carotidynia, which encompasses pain syndromes caused by non-inflammatory conditions of the carotid or vertebral arteries. (See  <a class="medical medical_review" href="/z/d/html/3355.html" rel="external">"Overview of craniofacial pain", section on 'Secondary causes'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Headache syndromes, including temporal arteritis (giant cell arteritis [GCA]), migraines, cluster, and tension headaches. (See  <a class="medical medical_review" href="/z/d/html/3349.html" rel="external">"Evaluation of headache in adults"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>In GCA, the headache is typically unilateral. In addition, nearly one-half of GCA patients experience jaw claudication, characterized by mandibular pain or fatigue brought on by mastication and relieved by stopping. However, unlike temporomandibular disorders (TMD), there is classically a palpable, tender, pulseless temporal artery on examination in GCA. (See  <a class="medical medical_review" href="/z/d/html/8225.html" rel="external">"Clinical manifestations of giant cell arteritis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Migraine headaches are typically unilateral, but unlike TMD are often accompanied by nausea, vomiting, and phono- or photophobia. (See  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Cluster headaches are characterized by unilateral orbital, supraorbital, or temporal pain. However, unlike TMD-related headaches, cluster headaches are accompanied by autonomic symptoms ipsilateral to the pain, such as ptosis, miosis, lacrimation, conjunctival injection, rhinorrhea, and nasal congestion. Occasionally, symptoms may involve the upper jaw and can be mistaken for dental pain. (See  <a class="medical medical_review" href="/z/d/html/3326.html" rel="external">"Cluster headache: Epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Tension-type headaches and TMD can present with similar symptoms: They may be distinct but overlapping conditions, or they may exist as part of a continuum of headache disorders [<a href="#rid77">77</a>]. When seen together, they need to be addressed concurrently [<a href="#rid78">78</a>]. (See  <a class="medical medical_review" href="/z/d/html/3357.html" rel="external">"Tension-type headache in adults: Etiology, clinical features, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/3360.html" rel="external">"Tension-type headache in adults: Preventive treatment"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Temporomandibular joint (TMJ) dislocation is an acute, painful event which typically follows extreme jaw opening (eg, yawning, shouting). On examination, the patient is unable to close their mouth, and a depression may be noted in the preauricular area where the mandibular condyle has come out of the fossa. (See  <a class="medical medical_review" href="/z/d/html/6333.html" rel="external">"Temporomandibular joint (TMJ) dislocation"</a> and  <a class="medical medical_review" href="/z/d/html/343.html" rel="external">"Initial evaluation and management of facial trauma in adults"</a>.)</p><p></p><p class="headingAnchor" id="H26338376"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Our management approach is based upon clinical experience, as there are few high-quality data informing the treatment of temporomandibular disorders (TMD) [<a href="#rid79">79-90</a>].</p><p>Our approach is similar to that used in other pain conditions, with a combined, multi-modal treatment strategy. We begin with patient education and self-care for all patients, and we use adjunctive pharmacotherapy when necessary. For those patients with a prominent muscular component to their pain, an occlusal splint (worn at night and/or during the day) along with physical therapy can be helpful; for patients with psychological comorbidities that increase the risk for developing chronic pain or disabling symptoms, we refer for biobehavioral management. In addition, trigger point, botulinum toxin, and intraarticular temporomandibular joint (TMJ) injections may also have a role.</p><p>In a 2023 network meta-analysis of 153 trials comparing therapies for chronic pain due to TMD, the three most effective therapies (determined by decrease in pain reported on a visual analog scale) were cognitive behavioral therapy with biofeedback or relaxation therapy, therapist-assisted jaw mobilization, and manual trigger point therapy [<a href="#rid91">91</a>].</p><p>In another 2023 network meta-analysis, evidence supported a different treatment approach for patients with symptoms related to the masticatory muscles (TMD-M) compared with the temporomandibular joint (TMD-J) [<a href="#rid92">92</a>]. For TMD-M, wet needling techniques were most effective, while other treatment approaches, including NSAIDs, were best for patients with symptoms of the temporomandibular joint.</p><p>For patients who have persistent functional limitations despite three to six months of nonsurgical management, and who have structural anatomic pathology or intraarticular disorders, surgical intervention may be a treatment option.</p><p class="headingAnchor" id="H6356317"><span class="h2">Initial management for all patients</span></p><p class="headingAnchor" id="H1165515331"><span class="h3">Patient education and self-care</span><span class="headingEndMark"> — </span>For all patients with TMD, we suggest education and self-care measures. We provide education regarding the natural history of the condition and the rationale behind our treatment approach [<a href="#rid93">93</a>]. In addition, individuals are counseled on self-care measures including optimal head posture, jaw exercises  (<a class="graphic graphic_picture graphicRef82044" href="/z/d/graphic/82044.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef58921" href="/z/d/graphic/58921.html" rel="external">picture 3</a>), proper sleep hygiene, as well as avoidance of triggers (eg, oral behaviors such as nail biting, pen chewing) if these factors contribute to symptoms. Patients typically improve with these conservative interventions.</p><p>There are limited high-quality data supporting the use of self-care and education in the treatment of TMD [<a href="#rid93">93-96</a>]; however, given the lack of harm and the potential benefit, these interventions are appropriate for all patients.</p><p class="headingAnchor" id="H2382975146"><span class="h2">Evaluate and treat contributory factors</span></p><p class="headingAnchor" id="H2212380610"><span class="h3">Physical therapy for musculoskeletal causes</span><span class="headingEndMark"> — </span>For patients with TMD, particularly those with a prominent musculoskeletal component or cervical or shoulder symptoms, we refer for physical therapy evaluation and treatment. Components of physical therapy may include TMJ mobilization and stability exercises, massage (to jaw, facial, and/or neck muscles), and postural evaluation and instruction.</p><p>There is, however, a lack of high-quality data evaluating the overall efficacy of physical therapy in the management of TMD, with methodologic issues limiting comparison between treatments [<a href="#rid97">97-99</a>]. However, for patients with identifiable contributors, we find that physical therapy directed at the underlying cause of the TMD is often helpful. The efficacy of physical therapy interventions may vary depending upon the skill and experience of the physical therapy provider in treating TMD.</p><p class="headingAnchor" id="H88680923"><span class="h3">Occlusal (bite) splints for musculoskeletal symptoms or bruxism</span><span class="headingEndMark"> — </span>For some patients with TMD, particularly those with prominent musculoskeletal symptoms or evidence of bruxism, occlusal splints fitted by a dental clinician can be used as an adjunctive therapy along with other TMD treatments.</p><p>For TMD patients with musculoskeletal symptoms, occlusal splints (worn at night and/or during the day) can be helpful when used with a physical therapy program [<a href="#rid100">100</a>].</p><p>In addition, for some patients with TMD clearly attributable to bruxism, the use of occlusal splints fitted by a dental clinician can provide some relief of symptoms. However, evidence supporting the efficacy of occlusal splints among all patients with TMD is mixed with some systematic reviews demonstrating a benefit and others demonstrating no improvement [<a href="#rid101">101,102</a>].</p><p>The evaluation and diagnosis of bruxism (sleep-related and awake) are reviewed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/97873.html" rel="external">"Sleep-related bruxism (tooth grinding)"</a> and  <a class="medical medical_review" href="/z/d/html/99555.html" rel="external">"Polysomnography in the evaluation of abnormal movements during sleep", section on 'Sleep-related bruxism'</a>.)</p><p class="headingAnchor" id="H325796286"><span class="h3">Biobehavioral management for psychological contributors</span><span class="headingEndMark"> — </span>For patients with comorbid depression, anxiety, and stress disorders, biobehavioral management is used as adjunctive therapy in TMD treatment. Risk factors for chronic TMD may be similar to those for other chronic pain syndromes [<a href="#rid37">37,47</a>], and addressing psychological contributors to pain is an essential component of pain management consistent with a biopsychosocial pain model. (See  <a class="medical medical_review" href="/z/d/html/116196.html" rel="external">"Evaluation of chronic non-cancer pain in adults", section on 'Chronic pain in context'</a>.)</p><p>In some trials, the addition of biobehavioral management, including biofeedback and cognitive behavioral therapy [CBT]) to usual care resulted in short-term improvement in TMD symptoms [<a href="#rid103">103</a>] and reduced overall medical utilization [<a href="#rid104">104</a>]. In a meta-analysis including 15 trials of patients with TMD, CBT, either alone or in combination with biofeedback, resulted in long-term improvement in activity interference and pain level [<a href="#rid105">105</a>]. However, the meta-analysis was limited by the small number of high-quality trials and the risk of bias.</p><p class="headingAnchor" id="H1332354260"><span class="h2">Adjunctive pharmacologic therapy</span><span class="headingEndMark"> — </span>For patients with persistent symptoms despite education and self-care, we use adjunctive pharmacotherapy concurrently with other treatments. Although nonpharmacologic therapy is generally preferred over pharmacologic therapy, they are commonly used together in clinical practice [<a href="#rid106">106,107</a>].</p><p>We use nonsteroidal antiinflammatory drugs (NSAIDs), tricyclic antidepressants (TCAs), and muscle relaxants in the treatment of TMD [<a href="#rid82">82-85,87,108</a>]. Although these agents are used in the treatment of many acute and chronic pain disorders, particularly myofascial pain disorders, there is a lack of high-quality evidence supporting their efficacy in treating chronic TMD [<a href="#rid109">109</a>].</p><p class="headingAnchor" id="H1981651636"><span class="h3">NSAIDS for acute management</span><span class="headingEndMark"> — </span>For patients with persistent TMD pain, we suggest using an NSAID as first-line pharmacologic therapy. We generally treat patients with a 10- to 14-day course of a long-acting NSAID (eg, <a class="drug drug_general" data-topicid="9682" href="/z/d/drug information/9682.html" rel="external">naproxen</a> 250 to 500 mg orally twice daily) [<a href="#rid109">109</a>]. We encourage patients to take the lowest effective dose of an NSAID for the shortest period of time.</p><p>For patients unable to take oral NSAIDs, topical <a class="drug drug_general" data-topicid="9348" href="/z/d/drug information/9348.html" rel="external">diclofenac</a> massaged into the skin over the painful muscle or joint (1% gel, 2 to 4 g applied two to three times daily; or 2% solution, one to two pump actions applied two times daily) can be helpful. As with oral NSAIDS, we treat for the shortest possible period, generally no longer than 14 days.</p><p>NSAIDs are associated with well-known gastrointestinal and renal side effects. In addition, exposure to NSAIDS is associated with an increased risk of myocardial infarction, which may be related to the degree of cyclooxygenase 2 (COX-2) inhibition [<a href="#rid110">110</a>]. Cardiovascular and gastrointestinal risk factors should be assessed before prescribing NSAIDs. (See  <a class="medical medical_review" href="/z/d/html/7968.html" rel="external">"NSAIDs: Adverse cardiovascular effects"</a> and  <a class="medical medical_review" href="/z/d/html/7991.html" rel="external">"Nonselective NSAIDs: Overview of adverse effects"</a>.)</p><p><a class="drug drug_general" data-topicid="9242" href="/z/d/drug information/9242.html" rel="external">Acetaminophen</a> can also be helpful to relieve pain but has no antiinflammatory properties and may be less effective for many patients. When used, we advise acetaminophen 650 mg orally every six hours as needed (maximum 3 g per 24 hours) for most adults, although we would use a lower total daily dose for older adult patients and those with any hepatic impairment.</p><p class="headingAnchor" id="H2661336574"><span class="h4">Skeletal muscle relaxant for muscle tenderness</span><span class="headingEndMark"> — </span>For patients with tenderness of the muscles of mastication, we suggest treatment with a skeletal muscle relaxant in addition to an NSAID. Examples include:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9306" href="/z/d/drug information/9306.html" rel="external">Cyclobenzaprine</a> 5 to 10 mg orally once daily at bedtime</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9691" href="/z/d/drug information/9691.html" rel="external">Metaxalone</a> 400 to 800 mg orally every eight hours</p><p></p><p>For TMD, we generally prescribe the skeletal muscle relaxant to be taken as a scheduled dose rather than "as needed"; in our clinical experience, it is more effective for this indication when taken regularly.</p><p>Due to its sedating properties, we advise that <a class="drug drug_general" data-topicid="9306" href="/z/d/drug information/9306.html" rel="external">cyclobenzaprine</a> be taken only at bedtime; <a class="drug drug_general" data-topicid="9691" href="/z/d/drug information/9691.html" rel="external">metaxalone</a> is prescribed if daytime use is preferred. In addition, patients who may be more sensitive to the sedating effects of muscle relaxants may better tolerate a reduced starting dose, less frequent administration, and more gradual titration.</p><p>For most patients, we prescribe the muscle relaxant for 10 to 14 days only. However, some patients with persistent muscular pain may benefit from an additional week of treatment. In a trial of 41 patients with TMD, treatment with <a class="drug drug_general" data-topicid="9306" href="/z/d/drug information/9306.html" rel="external">cyclobenzaprine</a> (10 mg at night) was compared with <a class="drug drug_general" data-topicid="9284" href="/z/d/drug information/9284.html" rel="external">clonazepam</a> and placebo; cyclobenzaprine improved jaw pain upon awakening compared with the other groups [<a href="#rid83">83</a>].</p><p class="headingAnchor" id="H3629493774"><span class="h3">Tricyclic antidepressants for persistent pain</span><span class="headingEndMark"> — </span>For patients with persistent TMD symptoms that warrant continued adjunctive pharmacotherapy after two weeks of NSAID treatment (or three weeks for those patients taking additional skeletal muscle relaxants), we suggest treatment with a TCA.</p><p>We typically use <a class="drug drug_general" data-topicid="9711" href="/z/d/drug information/9711.html" rel="external">nortriptyline</a>, starting at 10 mg orally once daily at bedtime, increasing the dose at weekly intervals in 10 mg increments (based on response and tolerability) to a maximum dose of 25 to 50 mg once daily at bedtime. Higher doses may not be tolerated due to side effects (eg, dry mouth, somnolence, weight gain) and are rarely used for TMD patients. In our dental practice, we typically prescribe a maximum of 25 mg; if a higher dose is required, we prescribe it in consultation with the patient's primary care clinician or other appropriate consulting physician. It can take up to 6 to 12 weeks, including two weeks at the highest dose tolerated, for an adequate treatment trial.</p><p>For patients whose symptoms respond adequately to treatment with a TCA, we reduce the dose slowly using the same increments we used for up-titration, and we continue the patient on the lowest effective dose for approximately four more months. If pain management remains adequate, the medication is tapered off over a period of four to six weeks. If pain recurs as the TCA is tapered off, the medication taper is discontinued and the lowest effective TCA dose is resumed.</p><p>Treatment for TMD with tricyclic antidepressants has been found to be of benefit in some patients, especially if TMD is part of generalized chronic muscular pain [<a href="#rid23">23</a>]. As an example, in a small trial of 12 TMD patients, those treated with <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">amitriptyline</a> (25 mg daily for 14 days) had a decrease in pain compared with placebo (75 versus 28 percent, respectively) [<a href="#rid108">108</a>].</p><p>In older adults, starting doses of tricyclics should be reduced by one-half, and dose escalation should be done more slowly. We avoid the use of TCAs with greater anticholinergic effects (ie, <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">amitriptyline</a>) in this population. In addition, TCAs should be avoided in patients with cardiac conduction system abnormalities. (See  <a class="medical medical_review" href="/z/d/html/126633.html" rel="external">"Pharmacologic management of chronic non-cancer pain in adults", section on 'Tricyclic antidepressants'</a>.)</p><p class="headingAnchor" id="H611222368"><span class="h2">Interventional management for some patients</span><span class="headingEndMark"> — </span>For certain patients, such as those with severe arthritis of the TMJ and patients with persistent symptoms due to internal derangement and joint pathology, interventional treatments may be offered.</p><p class="headingAnchor" id="H2460980080"><span class="h3">Arthritis of the TMJ</span><span class="headingEndMark"> — </span>Patients with arthritis of the TMJ (documented on imaging) are generally managed in the same way as other TMD patients (eg, self-care and education, physical therapy, occlusal splints, behavioral therapy, adjunctive pharmacotherapy). However, some may have persistent symptoms and may benefit from interventional management.</p><p>In a systematic review including randomized trials evaluating different intraarticular injections (eg, <a class="drug drug_general" data-topicid="8643" href="/z/d/drug information/8643.html" rel="external">hyaluronic acid</a>, corticosteroids, and blood products such as platelet-rich plasma), all studied injectables (in conjunction with arthrocentesis) were effective in alleviating pain and improving mandibular function in TMJ osteoarthritis [<a href="#rid111">111</a>]. In a meta-analysis of randomized clinical trials including patients with arthritis of the TMJ, there was moderate-quality evidence that minimally invasive TMJ procedures, including intraarticular injections, improved pain and function compared with noninterventional treatments in the short and intermediate term [<a href="#rid112">112</a>].</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Osteoarthritis</strong> – Patients with TMJ osteoarthritis (documented on imaging) and acute pain may benefit from intraarticular injection of a long-acting glucocorticoid (eg, <a class="drug drug_general" data-topicid="9068" href="/z/d/drug information/9068.html" rel="external">beclomethasone</a>) or <a class="drug drug_general" data-topicid="8643" href="/z/d/drug information/8643.html" rel="external">hyaluronic acid</a> into the joint [<a href="#rid78">78,113-117</a>].</p><p></p><p class="bulletIndent1">We prefer glucocorticoid injection rather than <a class="drug drug_general" data-topicid="8643" href="/z/d/drug information/8643.html" rel="external">hyaluronic acid</a>, and we typically use 10 mg <a class="drug drug_general" data-topicid="9639" href="/z/d/drug information/9639.html" rel="external">methylprednisolone</a> injected into the upper joint space (0.5 mL of a 20 mg/mL solution) following a local auriculotemporal nerve block using <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a> 0.5% with <a class="drug drug_general" data-topicid="9409" href="/z/d/drug information/9409.html" rel="external">epinephrine</a>. There are few high-quality data demonstrating the efficacy of this approach, but in our clinical experience an injection can provide symptomatic relief of pain for up to six months in selected patients [<a href="#rid115">115</a>].</p><p></p><p class="bulletIndent1">In general, we limit injections to two to three injections separated by at least four to six weeks. If there is no clinical response to the first injection, a second injection may be given; if there is no response to the second injection, no further injections are offered. Injections are reserved for patients with significant arthritic change. Those patients whose symptoms are refractory to injections may be candidates for surgical intervention. (See <a class="local">'Refractory temporomandibular disorders'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Rheumatoid arthritis </strong>– For patients with TMD and rheumatoid arthritis affecting the TMJ, in addition to the standard initial management for TMD, patients are referred for appropriate medical management of rheumatoid arthritis. (See  <a class="medical medical_review" href="/z/d/html/7516.html" rel="external">"General principles and overview of management of rheumatoid arthritis in adults"</a>.)</p><p></p><p class="bulletIndent1">If medical management of rheumatoid arthritis is inadequate in controlling symptoms, surgical treatment may be appropriate. (See <a class="local">'Refractory temporomandibular disorders'</a> below.)</p><p></p><p class="headingAnchor" id="H1165515339"><span class="h3">Refractory temporomandibular disorders</span><span class="headingEndMark"> — </span>For patients with TMD symptoms refractory to noninvasive management, including self-care and education, physical therapy, occlusal splints, behavioral therapy, and adjunctive pharmacotherapy, referral to an oral and maxillofacial surgeon with experience in managing TMD is warranted. Treatment options for these patients include trigger point muscle injections [<a href="#rid118">118</a>], botulinum toxin injections, intraarticular injections, or, in some patients, surgery, such as arthrocentesis, arthroscopy, arthroplasty, or TMJ reconstruction [<a href="#rid119">119,120</a>].</p><p>For TMD patients with predominantly musculoskeletal symptoms, trigger point injections and botulinum injections might be beneficial. Botulinum toxin can be injected into the masseter and temporalis muscles; this can also be combined with trigger point injections of long-acting local anesthesia (eg, <a class="drug drug_general" data-topicid="9169" href="/z/d/drug information/9169.html" rel="external">bupivacaine</a>) into the temporalis tendon and other muscles [<a href="#rid121">121</a>].</p><p>For some patients, such as those who have structural anatomic pathology on imaging (eg, internal derangement of the TMJ including displacement of the disc meniscus) and persistent jaw locking severe enough to interfere with activities of daily living despite three to six months of nonsurgical management, we suggest surgical intervention. The specific surgical intervention indicated will depend upon the specific intraarticular disorder [<a href="#rid120">120,122-126</a>]. As examples, severe condylar destruction due to osteoarthritis, rheumatoid arthritis, or progressive condylar resorption may cause pain, limitation of motion, and bite change; in such cases, joint reconstruction with costochondral grafts or total joint prostheses may be necessary. In these patients, jaw motion and occlusion can often be restored and quality of life improved with surgery [<a href="#rid127">127,128</a>]. However, pain relief from surgical intervention is more variable as there is often a myofascial pain component and chronic pain that requires multimodal management.</p><p class="headingAnchor" id="H1933691954"><span class="h1">TREATMENTS OF LIMITED VALUE</span><span class="headingEndMark"> — </span>Benzodiazepines and opioids are infrequently used in the management of temporomandibular disorders (TMD). Rarely, we may prescribe them for a patient with acute, severe pain (eg, as a result of trauma); however, symptoms are rarely severe enough to justify their use. Further, there is no evidence to support the long-term use of benzodiazepines or opioids in the management of TMD [<a href="#rid83">83,109,129</a>]. Further, there are risks of substance use disorder and overdose, particularly if taken in combination, and the risk and benefits should be carefully evaluated before prescribing them [<a href="#rid130">130</a>].</p><p>Prolotherapy, the injection of a 12 to 15% dextrose solution into the temporomandibular joint (TMJ), is being used as an option in some patients with persistent TMD symptoms, although there is limited high-quality evidence to support its use [<a href="#rid131">131-133</a>].</p><p>There are no high-quality data supporting the efficacy of alternative and complementary therapies in the management of TMD [<a href="#rid134">134,135</a>].</p><p class="headingAnchor" id="H1713551773"><span class="h1">PROGNOSIS</span><span class="headingEndMark"> — </span>In the general population, temporomandibular disorder (TMD) symptoms are self-limiting and majority of individuals respond well to treatment, although a small minority of patients will go on to develop chronic TMD. Almost 90 percent of patients with TMD respond to noninvasive treatments [<a href="#rid136">136</a>].</p><p class="headingAnchor" id="H2716929862"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/82988.html" rel="external">"Patient education: Temporomandibular joint (TMJ) disorders (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H26338383"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – Several factors can contribute to the development of temporomandibular disorder (TMD) symptoms, including temporomandibular joint (TMJ) trauma, poor head and cervical posture, differences in pain threshold and processing, and psychological factors such as depression and anxiety. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical manifestations</strong> – Symptoms of TMD most commonly include facial pain: a dull, unilateral facial ache that is constant but waxes and wanes in intensity and is typically aggravated by jaw motion. Other common symptoms include earache, headache (typically frontal or temporal and often radiating to the jaw), and jaw and TMJ dysfunction (eg, decreased mandibular range of motion, clicking with jaw movement, intermittent jaw locking). (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation and diagnosis</strong> – The diagnosis of TMD is based primarily upon the history, including the patient's constellation of symptoms, and compatible physical examination findings. For patients with more severe symptoms and those with persistent symptoms, we obtain imaging to rule out local pathology in the teeth and jaw bones; a panoramic radiograph or cone beam computed tomography (CBCT) are both reasonable choices. We advise against the routine use of a standard radiograph of the TMJ, as this study does not provide valuable information regarding dentition and mandibular alignment and symmetry. (See <a class="local">'Evaluation'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Initial management with patient education and self-care measures</strong> – For all patients with TMD, we suggest initial management with education and self-care measures (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). This includes education regarding the natural history of TMD and counseling on optimal head posture, jaw exercises  (<a class="graphic graphic_picture graphicRef82044" href="/z/d/graphic/82044.html" rel="external">picture 2</a> and <a class="graphic graphic_picture graphicRef58921" href="/z/d/graphic/58921.html" rel="external">picture 3</a>), and proper sleep hygiene, as well as avoidance of triggers (eg, oral behaviors such as nail biting, pen chewing) if these factors contribute to symptoms. There are limited high-quality data supporting the use of self-care and education in the treatment of TMD; however, given the lack of harm and the potential benefit, these interventions are appropriate for all patients. (See <a class="local">'Initial management for all patients'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Physical therapy for musculoskeletal causes</strong> – For patients with a prominent musculoskeletal component or cervical or shoulder symptoms, we refer for physical therapy evaluation and treatment. (See <a class="local">'Physical therapy for musculoskeletal causes'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Oclusal (bite) splints as adjunctive therapy</strong> – For some patients with TMD, particularly those with prominent musculoskeletal symptoms or evidence of bruxism, occlusal splints fitted by a dental clinician can be used as an adjunctive therapy along with other TMD treatments such as physical therapy. (See <a class="local">'Occlusal (bite) splints for musculoskeletal symptoms or bruxism'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Biobehavioral management for comorbid psychological conditions</strong> – For patients with comorbid depression, anxiety, and stress disorders, biobehavioral management is used as adjunctive therapy in TMD treatment. (See <a class="local">'Biobehavioral management for psychological contributors'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adjunctive pharmacotherapy for persistent symptoms</strong> – For patients with persistent symptoms despite education and self-care, we use adjunctive pharmacotherapy concurrently with other treatments. (See <a class="local">'Adjunctive pharmacologic therapy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For such patients, we suggest using a nonsteroidal antiinflammatory drug (NSAID) as first-line pharmacologic therapy rather than other medications (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). We generally treat patients with a 10- to 14-day course of a long-acting NSAID (eg, <a class="drug drug_general" data-topicid="9682" href="/z/d/drug information/9682.html" rel="external">naproxen</a> 250 to 500 mg orally twice daily). (See <a class="local">'NSAIDS for acute management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with tenderness of the muscles of mastication, we suggest treatment with a skeletal muscle relaxant in addition to the NSAID (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). For most patients, we prescribe the muscle relaxant for 10 to 14 days only. However, some patients with persistent muscular pain may benefit from an additional week of treatment. (See <a class="local">'Skeletal muscle relaxant for muscle tenderness'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>For patients with persistent TMD symptoms that warrant continued adjunctive pharmacotherapy after two weeks of NSAID treatment (or three weeks for those patients taking additional skeletal muscle relaxants), we suggest treatment with a tricyclic antidepressant (TCA) rather than other therapies (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Tricyclic antidepressants for persistent pain'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Interventional management for severe or refractory symptoms</strong> – For patients with TMD symptoms refractory to noninvasive management, referral to an oral and maxillofacial surgeon with experience in managing TMD is warranted. Treatment options for these patients include trigger point muscle injections, botulinum toxin injections, and intraarticular injections. (See <a class="local">'Interventional management for some patients'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surgical referral for refractory symptoms despite nonsurgical interventions</strong> – For some patients, such as those who have structural anatomic pathology on imaging and persistent jaw locking severe enough to interfere with activities of daily living despite three to six months of nonsurgical management, we suggest surgical intervention rather than no surgery (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). Although the specific surgery offered will depend upon the intraarticular disorder, such patients are unlikely to achieve adequate symptom control without surgical intervention. (See <a class="local">'Refractory temporomandibular disorders'</a> above.)</p><p></p><p class="headingAnchor" id="H800495437"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Steven Scrivani, DMD, DMedSc, who contributed to an earlier version of this topic review.</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Klasser GD, Manfredini D, Goulet JP, De Laat A. Oro-facial pain and temporomandibular disorders classification systems: A critical appraisal and future directions. J Oral Rehabil 2018; 45:258.</a></li><li><a class="nounderline abstract_t">Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38:1.</a></li><li><a class="nounderline abstract_t">International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia 2020; 40:129.</a></li><li><a class="nounderline abstract_t">Valesan LF, Da-Cas CD, Réus JC, et al. Prevalence of temporomandibular joint disorders: a systematic review and meta-analysis. Clin Oral Investig 2021; 25:441.</a></li><li><a class="nounderline abstract_t">Maixner W, Diatchenko L, Dubner R, et al. Orofacial pain prospective evaluation and risk assessment study--the OPPERA study. J Pain 2011; 12:T4.</a></li><li><a class="nounderline abstract_t">White BA, Williams LA, Leben JR. Health care utilization and cost among health maintenance organization members with temporomandibular disorders. J Orofac Pain 2001; 15:158.</a></li><li><a class="nounderline abstract_t">Von Korff M, Le Resche L, Dworkin SF. First onset of common pain symptoms: a prospective study of depression as a risk factor. Pain 1993; 55:251.</a></li><li><a class="nounderline abstract_t">LeResche L. Epidemiology of temporomandibular disorders: implications for the investigation of etiologic factors. Crit Rev Oral Biol Med 1997; 8:291.</a></li><li><a class="nounderline abstract_t">Slade GD, Bair E, By K, et al. Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study. J Pain 2011; 12:T12.</a></li><li><a class="nounderline abstract_t">Ferrando M, Andreu Y, Galdón MJ, et al. Psychological variables and temporomandibular disorders: distress, coping, and personality. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2004; 98:153.</a></li><li><a class="nounderline abstract_t">Manfredini D, di Poggio AB, Romagnoli M, et al. Mood spectrum in patients with different painful temporomandibular disorders. Cranio 2004; 22:234.</a></li><li><a class="nounderline abstract_t">Dworkin SF, Sherman J, Mancl L, et al. Reliability, validity, and clinical utility of the research diagnostic criteria for Temporomandibular Disorders Axis II Scales: depression, non-specific physical symptoms, and graded chronic pain. J Orofac Pain 2002; 16:207.</a></li><li><a class="nounderline abstract_t">Auerbach SM, Laskin DM, Frantsve LM, Orr T. Depression, pain, exposure to stressful life events, and long-term outcomes in temporomandibular disorder patients. J Oral Maxillofac Surg 2001; 59:628.</a></li><li><a class="nounderline abstract_t">Turner JA, Dworkin SF, Mancl L, et al. The roles of beliefs, catastrophizing, and coping in the functioning of patients with temporomandibular disorders. Pain 2001; 92:41.</a></li><li><a class="nounderline abstract_t">Campbell LC, Riley JL 3rd, Kashikar-Zuck S, et al. Somatic, affective, and pain characteristics of chronic TMD patients with sexual versus physical abuse histories. J Orofac Pain 2000; 14:112.</a></li><li><a class="nounderline abstract_t">Fillingim RB, Maixner W, Sigurdsson A, Kincaid S. Sexual and physical abuse history in subjects with temporomandibular disorders: relationship to clinical variables, pain sensitivity, and psychologic factors. J Orofac Pain 1997; 11:48.</a></li><li><a class="nounderline abstract_t">Liu F, Steinkeler A. Epidemiology, diagnosis, and treatment of temporomandibular disorders. Dent Clin North Am 2013; 57:465.</a></li><li><a class="nounderline abstract_t">Mortazavi N, Babaei M, Babaee N, et al. Evaluation of the Prevalence of Temporomandibular Joint Involvement in Rheumatoid Arthritis Using Research Diagnostic Criteria for Temporomandibular Disorders. J Dent (Tehran) 2018; 15:332.</a></li><li><a class="nounderline abstract_t">Cordeiro PC, Guimaraes JP, de Souza VA, et al. Temporomandibular joint involvement in rheumatoid arthritis patients: association between clinical and tomographic data. Acta Odontol Latinoam 2016; 29:123.</a></li><li><a class="nounderline abstract_t">Bracco P, Debernardi C, Piancino MG, et al. Evaluation of the stomatognathic system in patients with rheumatoid arthritis according to the research diagnostic criteria for temporomandibular disorders. Cranio 2010; 28:181.</a></li><li><a class="nounderline abstract_t">Manfredini D, Lobbezoo F. Relationship between bruxism and temporomandibular disorders: a systematic review of literature from 1998 to 2008. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010; 109:e26.</a></li><li><a class="nounderline abstract_t">Slade GD, Ohrbach R, Greenspan JD, et al. Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies. J Dent Res 2016; 95:1084.</a></li><li><a class="nounderline abstract_t">Scrivani SJ, Keith DA, Kaban LB. Temporomandibular disorders. N Engl J Med 2008; 359:2693.</a></li><li class="breakAll">Solberg WK. Epidemiology, Incidence and Prevalence of Temporomandibular Disorders: A Review. In: The President’s Conference on the Examination, Diagnosis and Management of Temporomandibular Disorders, American Dental Association, Chicago 1983. p.30.</li><li><a class="nounderline abstract_t">De Rossi SS, Greenberg MS, Liu F, Steinkeler A. Temporomandibular disorders: evaluation and management. Med Clin North Am 2014; 98:1353.</a></li><li><a class="nounderline abstract_t">Kothari SF, Baad-Hansen L, Svensson P. Psychosocial Profiles of Temporomandibular Disorder Pain Patients: Proposal of a New Approach to Present Complex Data. J Oral Facial Pain Headache 2017; 31:199.</a></li><li><a class="nounderline abstract_t">Rener-Sitar K, John MT, Pusalavidyasagar SS, et al. Sleep quality in temporomandibular disorder cases. Sleep Med 2016; 25:105.</a></li><li><a class="nounderline abstract_t">Ohrbach R, Dworkin SF. AAPT Diagnostic Criteria for Chronic Painful Temporomandibular Disorders. J Pain 2019; 20:1276.</a></li><li><a class="nounderline abstract_t">Ohrbach R, Slade GD, Bair E, et al. Premorbid and concurrent predictors of TMD onset and persistence. Eur J Pain 2020; 24:145.</a></li><li><a class="nounderline abstract_t">Häggman-Henrikson B, List T, Westergren HT, Axelsson SH. Temporomandibular disorder pain after whiplash trauma: a systematic review. J Orofac Pain 2013; 27:217.</a></li><li class="breakAll">Macleod DK. Common problems of the teeth and oral cavity. In: Principles of Ambulatory Medicine, 6th ed, Barker LR, Buron JR, Zieve PD, et al (Eds), Lippincott Williams &amp; Wilkins, 2003. p.1716.</li><li><a class="nounderline abstract_t">Milam SB, Zardeneta G, Schmitz JP. Oxidative stress and degenerative temporomandibular joint disease: a proposed hypothesis. J Oral Maxillofac Surg 1998; 56:214.</a></li><li><a class="nounderline abstract_t">Milam SB, Schmitz JP. Molecular biology of temporomandibular joint disorders: proposed mechanisms of disease. J Oral Maxillofac Surg 1995; 53:1448.</a></li><li><a class="nounderline abstract_t">Zardeneta G, Milam SB, Schmitz JP. Presence of denatured hemoglobin deposits in diseased temporomandibular joints. J Oral Maxillofac Surg 1997; 55:1242.</a></li><li><a class="nounderline abstract_t">Israel HA, Langevin CJ, Singer MD, Behrman DA. The relationship between temporomandibular joint synovitis and adhesions: pathogenic mechanisms and clinical implications for surgical management. J Oral Maxillofac Surg 2006; 64:1066.</a></li><li><a class="nounderline abstract_t">Ratcliffe A, Israel HA, Saed-Nejad F, Diamond B. Proteoglycans in the synovial fluid of the temporomandibular joint as an indicator of changes in cartilage metabolism during primary and secondary osteoarthritis. J Oral Maxillofac Surg 1998; 56:204.</a></li><li><a class="nounderline abstract_t">Forssell H, Kauko T, Kotiranta U, Suvinen T. Predictors for future clinically significant pain in patients with temporomandibular disorder: A prospective cohort study. Eur J Pain 2017; 21:188.</a></li><li><a class="nounderline abstract_t">Olivo SA, Bravo J, Magee DJ, et al. The association between head and cervical posture and temporomandibular disorders: a systematic review. J Orofac Pain 2006; 20:9.</a></li><li><a class="nounderline abstract_t">Shinozaki T, Sakamoto E, Shiiba S, et al. Cervical plexus block helps in diagnosis of orofacial pain originating from cervical structures. Tohoku J Exp Med 2006; 210:41.</a></li><li><a class="nounderline abstract_t">Bragdon EE, Light KC, Costello NL, et al. Group differences in pain modulation: pain-free women compared to pain-free men and to women with TMD. Pain 2002; 96:227.</a></li><li><a class="nounderline abstract_t">de Leeuw R, Albuquerque R, Okeson J, Carlson C. The contribution of neuroimaging techniques to the understanding of supraspinal pain circuits: implications for orofacial pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005; 100:308.</a></li><li><a class="nounderline abstract_t">Shah JP, Gilliams EA. Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome. J Bodyw Mov Ther 2008; 12:371.</a></li><li><a class="nounderline abstract_t">Nackley AG, Tan KS, Fecho K, et al. Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors. Pain 2007; 128:199.</a></li><li><a class="nounderline abstract_t">Diatchenko L, Nackley AG, Slade GD, et al. Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli. Pain 2006; 125:216.</a></li><li><a class="nounderline abstract_t">Diatchenko L, Anderson AD, Slade GD, et al. Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder. Am J Med Genet B Neuropsychiatr Genet 2006; 141B:449.</a></li><li><a class="nounderline abstract_t">Maixner W, Greenspan JD, Dubner R, et al. Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011; 12:T75.</a></li><li><a class="nounderline abstract_t">Sanders C, Liegey-Dougall A, Haggard R, et al. Temporomandibular Disorder Diagnostic Groups Affect Outcomes Independently of Treatment in Patients at Risk for Developing Chronicity: A 2-Year Follow-Up Study. J Oral Facial Pain Headache 2016; 30:187.</a></li><li><a class="nounderline abstract_t">Kindler S, Samietz S, Houshmand M, et al. Depressive and anxiety symptoms as risk factors for temporomandibular joint pain: a prospective cohort study in the general population. J Pain 2012; 13:1188.</a></li><li><a class="nounderline abstract_t">Cooper BC, Kleinberg I. Examination of a large patient population for the presence of symptoms and signs of temporomandibular disorders. Cranio 2007; 25:114.</a></li><li><a class="nounderline abstract_t">Mehta NR, Forgione AG, Rosenbaum RS, Holmberg R. "TMJ" triad of dysfunctions: a biologic basis of diagnosis and treatment. J Mass Dent Soc 1984; 33:173.</a></li><li><a class="nounderline abstract_t">Kuttila S, Kuttila M, Le Bell Y, et al. Characteristics of subjects with secondary otalgia. J Orofac Pain 2004; 18:226.</a></li><li><a class="nounderline abstract_t">Stepan L, Shaw CL, Oue S. Temporomandibular disorder in otolaryngology: systematic review. J Laryngol Otol 2017; 131:S50.</a></li><li><a class="nounderline abstract_t">Magalhães BG, Freitas JLM, Barbosa ACDS, et al. Temporomandibular disorder: otologic implications and its relationship to sleep bruxism. Braz J Otorhinolaryngol 2018; 84:614.</a></li><li><a class="nounderline abstract_t">Ren YF, Isberg A. Tinnitus in patients with temporomandibular joint internal derangement. Cranio 1995; 13:75.</a></li><li><a class="nounderline abstract_t">Johansson A, Unell L, Carlsson GE, et al. Gender difference in symptoms related to temporomandibular disorders in a population of 50-year-old subjects. J Orofac Pain 2003; 17:29.</a></li><li><a class="nounderline abstract_t">Graff-Radford SB, Abbott JJ. Temporomandibular Disorders and Headache. Oral Maxillofac Surg Clin North Am 2016; 28:335.</a></li><li><a class="nounderline abstract_t">Graff-Radford SB, Bassiur JP. Temporomandibular disorders and headaches. Neurol Clin 2014; 32:525.</a></li><li><a class="nounderline abstract_t">Macfarlane TV, Blinkhorn AS, Davies RM, et al. Oro-facial pain in the community: prevalence and associated impact. Community Dent Oral Epidemiol 2002; 30:52.</a></li><li><a class="nounderline abstract_t">Rasmussen P. Facial pain. IV. A prospective study of 1052 patients with a view of: precipitating factors, associated symptoms, objective psychiatric and neurological symptoms. Acta Neurochir (Wien) 1991; 108:100.</a></li><li><a class="nounderline abstract_t">Glaros AG, Urban D, Locke J. Headache and temporomandibular disorders: evidence for diagnostic and behavioural overlap. Cephalalgia 2007; 27:542.</a></li><li><a class="nounderline abstract_t">Gonçalves DA, Bigal ME, Jales LC, et al. Headache and symptoms of temporomandibular disorder: an epidemiological study. Headache 2010; 50:231.</a></li><li><a class="nounderline abstract_t">Mitrirattanakul S, Merrill RL. Headache impact in patients with orofacial pain. J Am Dent Assoc 2006; 137:1267.</a></li><li class="breakAll">Mehta NR, Scrivani SJ, Correa L, Matheson JK. Sleep-Related Bruxism. In: Therapy in Sleep Medicine, Barkoukis TJ, Matheson JK, Ferber R, Doghramji K (Eds), Elsevier, Philadelphia 2012. p.324.</li><li><a class="nounderline abstract_t">Fink M, Wähling K, Stiesch-Scholz M, Tschernitschek H. The functional relationship between the craniomandibular system, cervical spine, and the sacroiliac joint: a preliminary investigation. Cranio 2003; 21:202.</a></li><li><a class="nounderline abstract_t">Ciancaglini R, Testa M, Radaelli G. Association of neck pain with symptoms of temporomandibular dysfunction in the general adult population. Scand J Rehabil Med 1999; 31:17.</a></li><li><a class="nounderline abstract_t">Svensson P, Wang K, Sessle BJ, Arendt-Nielsen L. Associations between pain and neuromuscular activity in the human jaw and neck muscles. Pain 2004; 109:225.</a></li><li><a class="nounderline abstract_t">Fougeront N, Fleiter B. Temporomandibular disorder and comorbid neck pain: facts and hypotheses regarding pain-induced and rehabilitation-induced motor activity changes. Can J Physiol Pharmacol 2018; 96:1051.</a></li><li><a class="nounderline abstract_t">Fernandez de las Peñas C, Cuadrado ML, Gerwin RD, Pareja JA. Referred pain from the trochlear region in tension-type headache: a myofascial trigger point from the superior oblique muscle. Headache 2005; 45:731.</a></li><li class="breakAll">Kalina R, Orcutt J. Ocular and periocular pain. In: The Management of Pain, Bonica JJ (Ed), Lee and Ferbiger, Philadelphia 1990.</li><li><a class="nounderline abstract_t">Curtis AW. Myofascial pain-dysfunction syndrome: the role of nonmasticatory muscles in 91 patients. Otolaryngol Head Neck Surg 1980; 88:361.</a></li><li><a class="nounderline abstract_t">Schiffman E, Ohrbach R. Executive summary of the Diagnostic Criteria for Temporomandibular Disorders for clinical and research applications. J Am Dent Assoc 2016; 147:438.</a></li><li><a class="nounderline abstract_t">Bonato LL, Quinelato V, De Felipe Cordeiro PC, et al. Association between temporomandibular disorders and pain in other regions of the body. J Oral Rehabil 2017; 44:9.</a></li><li><a class="nounderline abstract_t">Fillingim RB, Ohrbach R, Greenspan JD, et al. Psychological factors associated with development of TMD: the OPPERA prospective cohort study. J Pain 2013; 14:T75.</a></li><li class="breakAll">http://www.brighamandwomens.org/Patients_Visitors/pcs/rehabilitationservices/Physical%20Therapy%20Standards%20of%20Care%20and%20Protocols/TMJ%20disorder.pdf (Accessed on November 28, 2012).</li><li><a class="nounderline abstract_t">Reneker J, Paz J, Petrosino C, Cook C. Diagnostic accuracy of clinical tests and signs of temporomandibular joint disorders: a systematic review of the literature. J Orthop Sports Phys Ther 2011; 41:408.</a></li><li><a class="nounderline abstract_t">Durham J, Newton-John TR, Zakrzewska JM. Temporomandibular disorders. BMJ 2015; 350:h1154.</a></li><li><a class="nounderline abstract_t">Mongini F. Temporomandibular disorders and tension-type headache. Curr Pain Headache Rep 2007; 11:465.</a></li><li><a class="nounderline abstract_t">Bergstrand S, Ingstad HK, Møystad A, Bjørnland T. Long-term effectiveness of arthrocentesis with and without hyaluronic acid injection for treatment of temporomandibular joint osteoarthritis. J Oral Sci 2019; 61:82.</a></li><li><a class="nounderline abstract_t">Truelove E, Huggins KH, Mancl L, Dworkin SF. The efficacy of traditional, low-cost and nonsplint therapies for temporomandibular disorder: a randomized controlled trial. J Am Dent Assoc 2006; 137:1099.</a></li><li><a class="nounderline abstract_t">Dionne RA. Pharmacologic treatments for temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997; 83:134.</a></li><li><a class="nounderline abstract_t">Ta LE, Dionne RA. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen. Pain 2004; 111:13.</a></li><li><a class="nounderline abstract_t">List T, Axelsson S, Leijon G. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review. J Orofac Pain 2003; 17:301.</a></li><li><a class="nounderline abstract_t">Herman CR, Schiffman EL, Look JO, Rindal DB. The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial. J Orofac Pain 2002; 16:64.</a></li><li><a class="nounderline abstract_t">Denucci DJ, Dionne RA, Dubner R. Identifying a neurobiologic basis for drug therapy in TMDs. J Am Dent Assoc 1996; 127:581.</a></li><li><a class="nounderline abstract_t">Singer E, Dionne R. A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain. J Orofac Pain 1997; 11:139.</a></li><li><a class="nounderline abstract_t">Dao TT, Lavigne GJ. Oral splints: the crutches for temporomandibular disorders and bruxism? Crit Rev Oral Biol Med 1998; 9:345.</a></li><li><a class="nounderline abstract_t">Fricton J. Myogenous temporomandibular disorders: diagnostic and management considerations. Dent Clin North Am 2007; 51:61.</a></li><li><a class="nounderline abstract_t">Fricton J. Current evidence providing clarity in management of temporomandibular disorders: summary of a systematic review of randomized clinical trials for intra-oral appliances and occlusal therapies. J Evid Based Dent Pract 2006; 6:48.</a></li><li><a class="nounderline abstract_t">Dworkin SF. The case for incorporating biobehavioral treatment into TMD management. J Am Dent Assoc 1996; 127:1607.</a></li><li><a class="nounderline abstract_t">Crider A, Glaros AG, Gevirtz RN. Efficacy of biofeedback-based treatments for temporomandibular disorders. Appl Psychophysiol Biofeedback 2005; 30:333.</a></li><li><a class="nounderline abstract_t">Yao L, Sadeghirad B, Li M, et al. Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials. BMJ 2023; 383:e076226.</a></li><li><a class="nounderline abstract_t">Christidis N, Al-Moraissi EA, Barjandi G, et al. Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis. Drugs 2024; 84:59.</a></li><li><a class="nounderline abstract_t">Dworkin SF, Huggins KH, Wilson L, et al. A randomized clinical trial using research diagnostic criteria for temporomandibular disorders-axis II to target clinic cases for a tailored self-care TMD treatment program. J Orofac Pain 2002; 16:48.</a></li><li><a class="nounderline abstract_t">Eliassen M, Hjortsjö C, Olsen-Bergem H, Bjørnland T. Self-exercise programmes and occlusal splints in the treatment of TMD-related myalgia-Evidence-based medicine? J Oral Rehabil 2019; 46:1088.</a></li><li><a class="nounderline abstract_t">Michelotti A, Iodice G, Vollaro S, et al. Evaluation of the short-term effectiveness of education versus an occlusal splint for the treatment of myofascial pain of the jaw muscles. J Am Dent Assoc 2012; 143:47.</a></li><li><a class="nounderline abstract_t">Story WP, Durham J, Al-Baghdadi M, et al. Self-management in temporomandibular disorders: a systematic review of behavioural components. J Oral Rehabil 2016; 43:759.</a></li><li><a class="nounderline abstract_t">McNeely ML, Armijo Olivo S, Magee DJ. A systematic review of the effectiveness of physical therapy interventions for temporomandibular disorders. Phys Ther 2006; 86:710.</a></li><li><a class="nounderline abstract_t">List T, Axelsson S. Management of TMD: evidence from systematic reviews and meta-analyses. J Oral Rehabil 2010; 37:430.</a></li><li><a class="nounderline abstract_t">Paço M, Peleteiro B, Duarte J, Pinho T. The Effectiveness of Physiotherapy in the Management of Temporomandibular Disorders: A Systematic Review and Meta-analysis. J Oral Facial Pain Headache 2016; 30:210.</a></li><li><a class="nounderline abstract_t">Al-Moraissi EA, Farea R, Qasem KA, et al. Effectiveness of occlusal splint therapy in the management of temporomandibular disorders: network meta-analysis of randomized controlled trials. Int J Oral Maxillofac Surg 2020; 49:1042.</a></li><li><a class="nounderline abstract_t">Ebrahim S, Montoya L, Busse JW, et al. The effectiveness of splint therapy in patients with temporomandibular disorders: a systematic review and meta-analysis. J Am Dent Assoc 2012; 143:847.</a></li><li><a class="nounderline abstract_t">Fouda AAH. No evidence on the effectiveness of oral splints for the management of temporomandibular joint dysfunction pain in both short and long-term follow-up systematic reviews and meta-analysis studies. J Korean Assoc Oral Maxillofac Surg 2020; 46:87.</a></li><li><a class="nounderline abstract_t">Dworkin SF, Turner JA, Mancl L, et al. A randomized clinical trial of a tailored comprehensive care treatment program for temporomandibular disorders. J Orofac Pain 2002; 16:259.</a></li><li><a class="nounderline abstract_t">Stowell AW, Gatchel RJ, Wildenstein L. Cost-effectiveness of treatments for temporomandibular disorders: biopsychosocial intervention versus treatment as usual. J Am Dent Assoc 2007; 138:202.</a></li><li><a class="nounderline abstract_t">Aggarwal VR, Lovell K, Peters S, et al. Psychosocial interventions for the management of chronic orofacial pain. Cochrane Database Syst Rev 2011; :CD008456.</a></li><li><a class="nounderline abstract_t">Häggman-Henrikson B, Alstergren P, Davidson T, et al. Pharmacological treatment of oro-facial pain - health technology assessment including a systematic review with network meta-analysis. J Oral Rehabil 2017; 44:800.</a></li><li><a class="nounderline abstract_t">Heir GM. The Efficacy of Pharmacologic Treatment of Temporomandibular Disorders. Oral Maxillofac Surg Clin North Am 2018; 30:279.</a></li><li><a class="nounderline abstract_t">Rizzatti-Barbosa CM, Nogueira MT, de Andrade ED, et al. Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders. Cranio 2003; 21:221.</a></li><li><a class="nounderline abstract_t">Mujakperuo HR, Watson M, Morrison R, Macfarlane TV. Pharmacological interventions for pain in patients with temporomandibular disorders. Cochrane Database Syst Rev 2010; :CD004715.</a></li><li><a class="nounderline abstract_t">Kearney PM, Baigent C, Godwin J, et al. Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials. BMJ 2006; 332:1302.</a></li><li><a class="nounderline abstract_t">Liapaki A, Thamm JR, Ha S, et al. Is there a difference in treatment effect of different intra-articular drugs for temporomandibular joint osteoarthritis? A systematic review of randomized controlled trials. Int J Oral Maxillofac Surg 2021; 50:1233.</a></li><li><a class="nounderline abstract_t">Al-Moraissi EA, Wolford LM, Ellis E 3rd, Neff A. The hierarchy of different treatments for arthrogenous temporomandibular disorders: A network meta-analysis of randomized clinical trials. J Craniomaxillofac Surg 2020; 48:9.</a></li><li><a class="nounderline abstract_t">de Souza RF, Lovato da Silva CH, Nasser M, et al. Interventions for the management of temporomandibular joint osteoarthritis. Cochrane Database Syst Rev 2012; :CD007261.</a></li><li><a class="nounderline abstract_t">Su N, Wang H, van Wijk AJ, et al. Prediction Models for Oral Health-Related Quality of Life in Patients with Temporomandibular Joint Osteoarthritis 1 and 6 Months After Arthrocentesis with Hyaluronic Acid Injections. J Oral Facial Pain Headache 2019; 33:54–66.</a></li><li><a class="nounderline abstract_t">Moldez MA, Camones VR, Ramos GE, et al. Effectiveness of Intra-Articular Injections of Sodium Hyaluronate or Corticosteroids for Intracapsular Temporomandibular Disorders: A Systematic Review and Meta-Analysis. J Oral Facial Pain Headache Winter; 32:53–66.</a></li><li><a class="nounderline abstract_t">Manfredini D, Piccotti F, Guarda-Nardini L. Hyaluronic acid in the treatment of TMJ disorders: a systematic review of the literature. Cranio 2010; 28:166.</a></li><li><a class="nounderline abstract_t">Sun H, Su Y, Song N, et al. Clinical Outcome of Sodium Hyaluronate Injection into the Superior and Inferior Joint Space for Osteoarthritis of the Temporomandibular Joint Evaluated by Cone-Beam Computed Tomography: A Retrospective Study of 51 Patients and 56 Joints. Med Sci Monit 2018; 24:5793.</a></li><li><a class="nounderline abstract_t">Ozkan F, Cakır Özkan N, Erkorkmaz U. Trigger point injection therapy in the management of myofascial temporomandibular pain. Agri 2011; 23:119.</a></li><li><a class="nounderline abstract_t">Breik O, Devrukhkar V, Dimitroulis G. Temporomandibular joint (TMJ) arthroscopic lysis and lavage: Outcomes and rate of progression to open surgery. J Craniomaxillofac Surg 2016; 44:1988.</a></li><li><a class="nounderline abstract_t">Israel HA. Part I: The use of arthroscopic surgery for treatment of temporomandibular joint disorders. J Oral Maxillofac Surg 1999; 57:579.</a></li><li><a class="nounderline abstract_t">Khawaja SN, Scrivani SJ, Holland N, Keith DA. Effectiveness, Safety, and Predictors of Response to Botulinum Toxin Type A in Refractory Masticatory Myalgia: A Retrospective Study. J Oral Maxillofac Surg 2017; 75:2307.</a></li><li><a class="nounderline abstract_t">Laskin DM. Arthroscopy Versus Arthrocentesis for Treating Internal Derangements of the Temporomandibular Joint. Oral Maxillofac Surg Clin North Am 2018; 30:325.</a></li><li><a class="nounderline abstract_t">McCain JP, de la Rua H, Le Blanc WG. Correlation of clinical, radiographic, and arthroscopic findings in internal derangements of the TMJ. J Oral Maxillofac Surg 1989; 47:913.</a></li><li><a class="nounderline abstract_t">Perrott DH, Alborzi A, Kaban LB, Helms CA. A prospective evaluation of the effectiveness of temporomandibular joint arthroscopy. J Oral Maxillofac Surg 1990; 48:1029.</a></li><li><a class="nounderline abstract_t">Nitzan DW, Dolwick MF, Heft MW. Arthroscopic lavage and lysis of the temporomandibular joint: a change in perspective. J Oral Maxillofac Surg 1990; 48:798.</a></li><li><a class="nounderline abstract_t">McCain JP, Sanders B, Koslin MG, et al. Temporomandibular joint arthroscopy: a 6-year multicenter retrospective study of 4,831 joints. J Oral Maxillofac Surg 1992; 50:926.</a></li><li><a class="nounderline abstract_t">Dimitroulis G. The role of surgery in the management of disorders of the Temporomandibular Joint: a critical review of the literature. Part 1. Int J Oral Maxillofac Surg 2005; 34:107.</a></li><li><a class="nounderline abstract_t">Dimitroulis G. The role of surgery in the management of disorders of the temporomandibular joint: a critical review of the literature. Part 2. Int J Oral Maxillofac Surg 2005; 34:231.</a></li><li><a class="nounderline abstract_t">DeNucci DJ, Sobiski C, Dionne RA. Triazolam improves sleep but fails to alter pain in TMD patients. J Orofac Pain 1998; 12:116.</a></li><li><a class="nounderline abstract_t">Keith DA, Hernández-Nuño de la Rosa MF. Special Screening Resources: Strategies to Identify Substance Use Disorders, Including Opioid Misuse and Abuse. Dent Clin North Am 2020; 64:513.</a></li><li><a class="nounderline abstract_t">Louw WF, Reeves KD, Lam SKH, et al. Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection (Prolotherapy): A Randomized Controlled Trial With Long-term Partial Crossover. Mayo Clin Proc 2019; 94:820.</a></li><li><a class="nounderline abstract_t">Zarate MA, Frusso RD, Reeves KD, et al. Dextrose Prolotherapy Versus Lidocaine Injection for Temporomandibular Dysfunction: A Pragmatic Randomized Controlled Trial. J Altern Complement Med 2020; 26:1064.</a></li><li><a class="nounderline abstract_t">Reeves KD, Sit RW, Rabago DP. Dextrose Prolotherapy: A Narrative Review of Basic Science, Clinical Research, and Best Treatment Recommendations. Phys Med Rehabil Clin N Am 2016; 27:783.</a></li><li><a class="nounderline abstract_t">Myers CD. Complementary and alternative medicine for persistent facial pain. Dent Clin North Am 2007; 51:263.</a></li><li><a class="nounderline abstract_t">Myers CD, White BA, Heft MW. A review of complementary and alternative medicine use for treating chronic facial pain. J Am Dent Assoc 2002; 133:1189.</a></li><li class="breakAll">Orofacial Pain: Guidelines for Assessment, Diagnosis, and Management, 4th ed, de Leeuw R (Ed), Quintessence Publishing, 2008.</li></ol></div><div id="topicVersionRevision">Topic 5629 Version 48.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29197095" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Oro-facial pain and temporomandibular disorders classification systems: A critical appraisal and future directions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29368949" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32103673" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : International Classification of Orofacial Pain, 1st edition (ICOP).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33409693" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Prevalence of temporomandibular joint disorders: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22074751" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Orofacial pain prospective evaluation and risk assessment study--the OPPERA study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11443827" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Health care utilization and cost among health maintenance organization members with temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8309712" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : First onset of common pain symptoms: a prospective study of depression as a risk factor.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9260045" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Epidemiology of temporomandibular disorders: implications for the investigation of etiologic factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22074749" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Study methods, recruitment, sociodemographic findings, and demographic representativeness in the OPPERA study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15316541" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Psychological variables and temporomandibular disorders: distress, coping, and personality.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15293779" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Mood spectrum in patients with different painful temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12221737" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Reliability, validity, and clinical utility of the research diagnostic criteria for Temporomandibular Disorders Axis II Scales: depression, non-specific physical symptoms, and graded chronic pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11381383" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Depression, pain, exposure to stressful life events, and long-term outcomes in temporomandibular disorder patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11323125" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : The roles of beliefs, catastrophizing, and coping in the functioning of patients with temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11203745" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Somatic, affective, and pain characteristics of chronic TMD patients with sexual versus physical abuse histories.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10332310" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Sexual and physical abuse history in subjects with temporomandibular disorders: relationship to clinical variables, pain sensitivity, and psychologic factors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23809304" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Epidemiology, diagnosis, and treatment of temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30842793" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Evaluation of the Prevalence of Temporomandibular Joint Involvement in Rheumatoid Arthritis Using Research Diagnostic Criteria for Temporomandibular Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28383601" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Temporomandibular joint involvement in rheumatoid arthritis patients: association between clinical and tomographic data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20806736" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Evaluation of the stomatognathic system in patients with rheumatoid arthritis according to the research diagnostic criteria for temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20451831" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Relationship between bruxism and temporomandibular disorders: a systematic review of literature from 1998 to 2008.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27339423" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Painful Temporomandibular Disorder: Decade of Discovery from OPPERA Studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19092154" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19092154" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25443680" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Temporomandibular disorders: evaluation and management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28738104" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Psychosocial Profiles of Temporomandibular Disorder Pain Patients: Proposal of a New Approach to Present Complex Data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27823702" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Sleep quality in temporomandibular disorder cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31004786" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : AAPT Diagnostic Criteria for Chronic Painful Temporomandibular Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31421009" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Premorbid and concurrent predictors of TMD onset and persistence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23882454" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Temporomandibular disorder pain after whiplash trauma: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23882454" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Temporomandibular disorder pain after whiplash trauma: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9461148" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Oxidative stress and degenerative temporomandibular joint disease: a proposed hypothesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7490656" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Molecular biology of temporomandibular joint disorders: proposed mechanisms of disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9371114" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Presence of denatured hemoglobin deposits in diseased temporomandibular joints.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16781339" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : The relationship between temporomandibular joint synovitis and adhesions: pathogenic mechanisms and clinical implications for surgical management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9461146" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Proteoglycans in the synovial fluid of the temporomandibular joint as an indicator of changes in cartilage metabolism during primary and secondary osteoarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27461164" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Predictors for future clinically significant pain in patients with temporomandibular disorder: A prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16483016" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The association between head and cervical posture and temporomandibular disorders: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16960344" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Cervical plexus block helps in diagnosis of orofacial pain originating from cervical structures.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11972994" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Group differences in pain modulation: pain-free women compared to pain-free men and to women with TMD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16122658" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : The contribution of neuroimaging techniques to the understanding of supraspinal pain circuits: implications for orofacial pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19083696" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Uncovering the biochemical milieu of myofascial trigger points using in vivo microdialysis: an application of muscle pain concepts to myofascial pain syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17084978" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Catechol-O-methyltransferase inhibition increases pain sensitivity through activation of both beta2- and beta3-adrenergic receptors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16837133" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Catechol-O-methyltransferase gene polymorphisms are associated with multiple pain-evoking stimuli.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16741943" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Three major haplotypes of the beta2 adrenergic receptor define psychological profile, blood pressure, and the risk for development of a common musculoskeletal pain disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22074754" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Potential autonomic risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27472521" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Temporomandibular Disorder Diagnostic Groups Affect Outcomes Independently of Treatment in Patients at Risk for Developing Chronicity: A 2-Year Follow-Up Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23141187" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Depressive and anxiety symptoms as risk factors for temporomandibular joint pain: a prospective cohort study in the general population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17508632" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Examination of a large patient population for the presence of symptoms and signs of temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6596381" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : "TMJ" triad of dysfunctions: a biologic basis of diagnosis and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15509002" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Characteristics of subjects with secondary otalgia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27786149" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Temporomandibular disorder in otolaryngology: systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28966039" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Temporomandibular disorder: otologic implications and its relationship to sleep bruxism.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8697503" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Tinnitus in patients with temporomandibular joint internal derangement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12756928" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Gender difference in symptoms related to temporomandibular disorders in a population of 50-year-old subjects.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27475510" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Temporomandibular Disorders and Headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24703543" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Temporomandibular disorders and headaches.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11918576" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Oro-facial pain in the community: prevalence and associated impact.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2031469" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Facial pain. IV. A prospective study of 1052 patients with a view of: precipitating factors, associated symptoms, objective psychiatric and neurological symptoms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17441972" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Headache and temporomandibular disorders: evidence for diagnostic and behavioural overlap.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19751369" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Headache and symptoms of temporomandibular disorder: an epidemiological study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16946432" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Headache impact in patients with orofacial pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16946432" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Headache impact in patients with orofacial pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12889677" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : The functional relationship between the craniomandibular system, cervical spine, and the sacroiliac joint: a preliminary investigation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10229999" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Association of neck pain with symptoms of temporomandibular dysfunction in the general adult population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15157682" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Associations between pain and neuromuscular activity in the human jaw and neck muscles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30067068" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Temporomandibular disorder and comorbid neck pain: facts and hypotheses regarding pain-induced and rehabilitation-induced motor activity changes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15953305" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Referred pain from the trochlear region in tension-type headache: a myofascial trigger point from the superior oblique muscle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15953305" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Referred pain from the trochlear region in tension-type headache: a myofascial trigger point from the superior oblique muscle.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6821416" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Myofascial pain-dysfunction syndrome: the role of nonmasticatory muscles in 91 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26922248" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Executive summary of the Diagnostic Criteria for Temporomandibular Disorders for clinical and research applications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27862166" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Association between temporomandibular disorders and pain in other regions of the body.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24275225" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Psychological factors associated with development of TMD: the OPPERA prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24275225" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Psychological factors associated with development of TMD: the OPPERA prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21335932" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Diagnostic accuracy of clinical tests and signs of temporomandibular joint disorders: a systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25767130" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18173983" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Temporomandibular disorders and tension-type headache.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30814387" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Long-term effectiveness of arthrocentesis with and without hyaluronic acid injection for treatment of temporomandibular joint osteoarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16873325" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : The efficacy of traditional, low-cost and nonsplint therapies for temporomandibular disorder: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9007937" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Pharmacologic treatments for temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15327804" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: a randomized placebo-controlled comparison of celecoxib to naproxen.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14737874" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11889661" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : The effectiveness of adding pharmacologic treatment with clonazepam or cyclobenzaprine to patient education and self-care for the treatment of jaw pain upon awakening: a randomized clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8642138" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Identifying a neurobiologic basis for drug therapy in TMDs.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10332320" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : A controlled evaluation of ibuprofen and diazepam for chronic orofacial muscle pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9715371" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Oral splints: the crutches for temporomandibular disorders and bruxism?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17185060" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Myogenous temporomandibular disorders: diagnostic and management considerations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17138397" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Current evidence providing clarity in management of temporomandibular disorders: summary of a systematic review of randomized clinical trials for intra-oral appliances and occlusal therapies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8952235" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : The case for incorporating biobehavioral treatment into TMD management.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16385422" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Efficacy of biofeedback-based treatments for temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/38101924" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Management of chronic pain secondary to temporomandibular disorders: a systematic review and network meta-analysis of randomised trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/38103150" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Pharmacological Treatments of Temporomandibular Disorders: A Systematic Review Including a Network Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11889659" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : A randomized clinical trial using research diagnostic criteria for temporomandibular disorders-axis II to target clinic cases for a tailored self-care TMD treatment program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31286551" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Self-exercise programmes and occlusal splints in the treatment of TMD-related myalgia-Evidence-based medicine?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22207667" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Evaluation of the short-term effectiveness of education versus an occlusal splint for the treatment of myofascial pain of the jaw muscles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27487973" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Self-management in temporomandibular disorders: a systematic review of behavioural components.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16649894" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : A systematic review of the effectiveness of physical therapy interventions for temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20438615" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Management of TMD: evidence from systematic reviews and meta-analyses.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27472523" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : The Effectiveness of Physiotherapy in the Management of Temporomandibular Disorders: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31982236" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Effectiveness of occlusal splint therapy in the management of temporomandibular disorders: network meta-analysis of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22855899" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : The effectiveness of splint therapy in patients with temporomandibular disorders: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32364348" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : No evidence on the effectiveness of oral splints for the management of temporomandibular joint dysfunction pain in both short and long-term follow-up systematic reviews and meta-analysis studies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12455427" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : A randomized clinical trial of a tailored comprehensive care treatment program for temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17272375" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Cost-effectiveness of treatments for temporomandibular disorders: biopsychosocial intervention versus treatment as usual.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22071849" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Psychosocial interventions for the management of chronic orofacial pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28884860" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Pharmacological treatment of oro-facial pain - health technology assessment including a systematic review with network meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30008340" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : The Efficacy of Pharmacologic Treatment of Temporomandibular Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12889679" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20927737" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Pharmacological interventions for pain in patients with temporomandibular disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16740558" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33642154" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Is there a difference in treatment effect of different intra-articular drugs for temporomandibular joint osteoarthritis? A systematic review of randomized controlled trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31870713" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : The hierarchy of different treatments for arthrogenous temporomandibular disorders: A network meta-analysis of randomized clinical trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22513948" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Interventions for the management of temporomandibular joint osteoarthritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30153315" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Prediction Models for Oral Health-Related Quality of Life in Patients with Temporomandibular Joint Osteoarthritis 1 and 6 Months After Arthrocentesis with Hyaluronic Acid Injections.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29244893" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Effectiveness of Intra-Articular Injections of Sodium Hyaluronate or Corticosteroids for Intracapsular Temporomandibular Disorders: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20806734" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Hyaluronic acid in the treatment of TMJ disorders: a systematic review of the literature.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30122753" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Clinical Outcome of Sodium Hyaluronate Injection into the Superior and Inferior Joint Space for Osteoarthritis of the Temporomandibular Joint Evaluated by Cone-Beam Computed Tomography: A Retrospective Study of 51 Patients and 56 Joints.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21935818" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : Trigger point injection therapy in the management of myofascial temporomandibular pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27836550" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Temporomandibular joint (TMJ) arthroscopic lysis and lavage: Outcomes and rate of progression to open surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10319832" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Part I: The use of arthroscopic surgery for treatment of temporomandibular joint disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29078865" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Effectiveness, Safety, and Predictors of Response to Botulinum Toxin Type A in Refractory Masticatory Myalgia: A Retrospective Study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29866452" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Arthroscopy Versus Arthrocentesis for Treating Internal Derangements of the Temporomandibular Joint.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2760727" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Correlation of clinical, radiographic, and arthroscopic findings in internal derangements of the TMJ.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2213290" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : A prospective evaluation of the effectiveness of temporomandibular joint arthroscopy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2374054" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Arthroscopic lavage and lysis of the temporomandibular joint: a change in perspective.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1506966" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Temporomandibular joint arthroscopy: a 6-year multicenter retrospective study of 4,831 joints.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15695036" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : The role of surgery in the management of disorders of the Temporomandibular Joint: a critical review of the literature. Part 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15741028" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : The role of surgery in the management of disorders of the temporomandibular joint: a critical review of the literature. Part 2.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9656889" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Triazolam improves sleep but fails to alter pain in TMD patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32448455" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Special Screening Resources: Strategies to Identify Substance Use Disorders, Including Opioid Misuse and Abuse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30878157" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Treatment of Temporomandibular Dysfunction With Hypertonic Dextrose Injection (Prolotherapy): A Randomized Controlled Trial With Long-term Partial Crossover.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32780636" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Dextrose Prolotherapy Versus Lidocaine Injection for Temporomandibular Dysfunction: A Pragmatic Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27788902" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Dextrose Prolotherapy: A Narrative Review of Basic Science, Clinical Research, and Best Treatment Recommendations.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17185070" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Complementary and alternative medicine for persistent facial pain.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12356250" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : A review of complementary and alternative medicine use for treating chronic facial pain.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
